Compound information
- Natural Products
- ZC220474
- Molecular Formula
- C15H20N2O6S
- Molecular Weight
- 356.10420736 g/mol
- Structure
-
- IUPAC Name
- ethyl 4-(4-methoxycarbonylphenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C15H20N2O6S/c1-3-23-15(19)16-8-10-17(11-9-16)24(20,21)13-6-4-12(5-7-13)14(18)22-2/h4-7H,3,8-11H2,1-2H3
- InChI Key
- GZHIHKLIRZQOEB-UHFFFAOYSA-N
- SMILES
- CCOC(=O)N1CCN(S(=O)(=O)c2ccc(C(=O)OC)cc2)CC1
- Source
- ZINC000015323927
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 2 |
Heteroatom Count | 9 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 93.22 Å2 | LogP | 1.847 |
LogS | -3.263 | LogD | 2.169 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.024 | Pgp substrate | 0.03 |
HIA | 0.975 | F20 % | 0.5 |
F30 % | 0.26 | Caco-2 | -4.4 |
MDCK | -4.627 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.357 | PPB | 67.956 |
VD | 1.092 | Fu | 0.648 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.209 | CYP1A2 substrate | 0.466 |
CYP2A6 substrate | 0.502 | CYP2B6 substrate | 0.601 |
CYP2C19 inhibitor | 0.683 | CYP2C19 substrate | 0.736 |
CYP2C8 substrate | 0.572 | CYP2C9 inhibitor | 0.768 |
CYP2C9 substrate | 0.999 | CYP2D6 inhibitor | 0.025 |
CYP2D6 substrate | 0.34 | CYP2E1 substrate | 0.284 |
CYP3A4 inhibitor | 0.023 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.564 | CL | 5.213 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.227 | Hepatotoxicity | 0.277 |
Mutagenicity | 0.228 | Rat Oral Acute Toxicity | 0.048 |
FDAMDD | 0.076 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.032 | Eye Corrosion | 0.001 |
Eye Irritation | 0.008 | Respiratory Toxicity | 0.015 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.823 | IGC50 | 3.279 |
LC50FM | 2.116 | LC50DM | -0.376 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.405 | NR-AR-LBD | 0.347 |
NR-AhR | 0.032 | NR-Aromatase | 0.019 |
NR-ER | 0.368 | NR-ER-LBD | 0.423 |
NR-PPAR-gamma | 0.108 | SR-ARE | 0.092 |
SR-ATAD5 | 0.329 | SR-HSE | 0.054 |
SR-MMP | 0.011 | SR-p53 | 0.028 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.